BB Biotech — Turning milestones into momentum
BB Biotech (BION) delivered strong Q325 results, underpinned by its focus on innovative biotech companies with differentiated clinical pipelines...
212 Views
BB Biotech — Optimistic about biotech’s long-term prospects
During 2024 and early this year, the biotech sector began to show signs of a structural recovery, supported by positive clinical data, regulatory...
298 Views
BB Biotech - A key milestone with significance for the sector
BB Biotech (BION) invests in innovative, rapidly expanding biotech companies. BION’s portfolio company Wave Life Sciences (Wave) recently announced...
252 Views
BB Biotech - Lower rates and news flow to support recovery
BB Biotech (BION) offers investors exposure to the innovative, rapidly expanding biotech sector. It is the largest biotech investor among its...
270 Views
BB Biotech - Positive trial news lifts two portfolio holdings
In our last BB Biotech (BION) review note, published in May 2024, we noted that the biotech sector was eagerly awaiting some key milestones, the...
366 Views